MIRA INFORM REPORT

 

 

Report Date :

11.01.2013

 

IDENTIFICATION DETAILS

 

Name :

VITAPAN INDÚSTRIA FARMACÊUTICA LTDA

 

 

Registered Office :

Vpr 1, Quadra 2a, Módulo,1 – Daia 75132-020 - Anápolis/Go

 

 

Country :

Brazil

 

 

Financials (as on) :

31.12.2011

 

 

Date of Incorporation :

02.09.1977

 

 

Legal Form :

Limited Liability Company

 

 

Line of Business :

Manufacturing and Trade of Pharmaceutical Products for Human Usage.

 

 

No. of Employees :

280

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30th, 2012

 

Country Name

Previous Rating

(31.03.2012)

Current Rating

(30.06.2012)

Brazil

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

Brazil - ECONOMIC OVERVIEW

 

Characterized by large and well-developed agricultural, mining, manufacturing, and service sectors, Brazil's economy outweighs that of all other South American countries, and Brazil is expanding its presence in world markets. Since 2003, Brazil has steadily improved its macroeconomic stability, building up foreign reserves, and reducing its debt profile by shifting its debt burden toward real denominated and domestically held instruments. In 2008, Brazil became a net external creditor and two ratings agencies awarded investment grade status to its debt. After strong growth in 2007 and 2008, the onset of the global financial crisis hit Brazil in 2008. Brazil experienced two quarters of recession, as global demand for Brazil's commodity-based exports dwindled and external credit dried up. However, Brazil was one of the first emerging markets to begin a recovery. In 2010, consumer and investor confidence revived and GDP growth reached 7.5%, the highest growth rate in the past 25 years. Rising inflation led the authorities to take measures to cool the economy; these actions and the deteriorating international economic situation slowed growth to 2.7% for 2011 as a whole, though forecasts for 2012 growth are somewhat higher. Despite slower growth in 2011, Brazil overtook the United Kingdom as the world's seventh largest economy in terms of GDP. Urban unemployment is at the historic low of 4.7% (December 2011), and Brazil's traditionally high level of income equality has declined for each of the last 12 years. Brazil's high interest rates make it an attractive destination for foreign investors. Large capital inflows over the past several years have contributed to the appreciation of the currency, hurting the competitiveness of Brazilian manufacturing and leading the government to intervene in foreign exchanges markets and raise taxes on some foreign capital inflows. President Dilma ROUSSEFF has retained the previous administration's commitment to inflation targeting by the central bank, a floating exchange rate, and fiscal restraint.

Source : CIA

 

 


Company name

 

VITAPAN INDÚSTRIA FARMACÊUTICA LTDA

 

 

ADDRESSES

 

MAIN ADDRESS:

VPR 1, QUADRA 2A, MÓDULO,1 - DAIA

ZIP CODE/CITY:

75132-020 - ANÁPOLIS/GO

 

 

PHONE:

62 3902-6100

FAX:

62 3902-6129

E-MAIL:

gsuprimentos@vitapan.com.br / suprimentos@vitapan.com.br

WEB SITE:

www.vitapan.com.br

 

BRANCHES:

 

NOT AVAILABLE.

 

 

LEGAL DATA

 

MAIN ACTIVITIES:

 

PHARMACEUTICAL INDUSTRY.

 

LEGAL FORM:

LIMITED LIABILITY COMPANY

 

 

INCORPORATION DATE:

02/09/1977

REGISTER DATE:

02/09/1977

BALANCE SHEET FILING DATE:

31/12

TAX CONTRIBUTOR NUMBER(CNPJ):

30.222.814/0001-31

STATE REGISTER:

10.197.801-4

 

 

SHARE CAPITAL:

R$ 5.200.000,00

 

BOARD OF DIRECTORS:

 

 

 

ANDREA APRIGIO DE SOUZA

MANAGER

ADRIANO APRIGIO DE SOUZA

MANAGER

 

 

AUTHORIZED USE OF SIGNATURE

 

THE MANAGERS ARE AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY.

 

SHAREHOLDERS / PARTNERS:

 

 

 

ANDREA APRIGIO DE SOUZA

95,0%

ADRIANO APRIGIO DE SOUZA

5,00%

 

AFFILIATES / SUBSIDIARIES:

 

 

 

APRIGIO CONSTRUTORA E INCORPORADORA LTDA

 

ICF - INST. DE CIÊNCIAS FARMAC. DE ESTUDOS E PESQUISAS LTDA

 

REDE BRASILTUR DE TELEVISÃO LTDA

 

RÁDIO GOIÁS SUL FM LTDA ME

 

 

 

COMPANY'S BACKGROUND

 

THE SUBJECT WAS ESTABLISHED ON SEPTEMBER 02, 1977 AS INSTITUTO TERAPÊUTICO VITAPAN LTDA TO BE ENGAGED IN THE SAID LINE OF BUSINESS. ON SEPTEMBER 10, 1991 IT ADOPTED THE ABOVE-MENTIONED NAME.

 

THE COMPANY OPERATES WITH THE TRADE NAME OF "VITAPAN"

 

PARTNERS:

 

ADRIANO APRIGIO DE SOUZA, BRAZILIAN, MARRIED, HOLDER OF DOCUMENTS, RG 2.640.123 SSP/GO E CPF 498.273.161-68, RESIDENTIAL ADDRESS AT RUA JOSÉ RODRIGUES, QUADRA 48, LOTE 12, APART. 1.602, EDIFÍCIO RESIDENCIAL FIRENZE, BAIRRO JUNDIAÍ - ANÁPOLIS/GO;

 

ANDRÉA APRIGIO DE SOUZA, BRAZILIAN, MARRIED, HOLDER OF DOCUMENTS, RG 2.874.239 SSP/GO E CPF 644.628.971-53, RESIDENTIAL ADDRESS AT AVENIDA 136, Nº 555, APART. 500, EDIFÍCIO RESIDENCIAL EXCALIBUR, SETOR MARISTA - GOIÂNIA/GO.

 

FURTHER DETAILS ARE SO FAR NOT KNOWN.

 

PUBLIC INFORMATION:

 

NO DETRIMENTAL FILES WERE FOUND.

 

 

FINANCIAL INFORMATION

 

GENERAL BALANCE SHEETS AS OF 31/12/2011, 31/12/2010 AND 31/12/2009.

( FIGURES ARE IN REAIS ).

 

ASSETS

 

 

 

CURRENT:

31/12/2011

31/12/2010

31/12/2009

 

 

 

 

CASH AND BANKS

940.969,24

43.910,00

31.750,00

CLIENTS

6.129.896,57

6.100.843,00

5.398.061,00

OTHER CREDITS

23.068,75

24.881,00

32.165,00

ADVANCE TO SUPPLIERS

679.450,79

446.342,00

550.064,00

RECOVERABLE TAXES

151.178,89

83.666,00

155.599,00

INVENTORY

2.391.741,18

2.511.181,00

3.084.739,00

PRE PAID EXPENSES

66.844,20

30.498,00

76.973,00

 

----------------

----------------

----------------

TOTAL CURRENT ASSETS

10.383.149,62

9.241.321,00

9.329.351,00

 

LONG-TERM RECEIVABLES:

 

 

 

 

 

 

 

TAX BENEFITS

 

10.360,00

9.173,00

RECOVERABLE TAXES

47.697,27

22.887,00

34.849,00

JUDICIAL DEPOSITS

 

60.783,00

70.758,00

MUTUAL CONTRACT

 

155.021,00

 

OTHER CREDITS

103.078,35

75.000,00

65.000,00

 

----------------

----------------

----------------

TOTAL LONG-TERM RECEIVABLES

150.775,62

324.051,00

179.780,00

 

FIXED ASSETS:

 

 

 

 

 

 

 

INVESTMENTS

1.070,70

1.071,00

1.071,00

FIXED ASSETS

7.605.145,76

6.983.009,00

7.570.482,00

DEFERRED

 

 

25.859,00

INTANGIBLE

664.835,03

639.941,00

362.526,00

 

----------------

----------------

----------------

TOTAL FIXED ASSETS

8.271.051,49

7.624.021,00

7.959.938,00

OFF-BALANCE ACCOUNTS

536.231,59

 

 

 

================

================

================

TOTAL ASSETS

19.341.208,32

17.189.393,00

17.469.069,00

 

LIABILITIES:

 

 

 

CURRENT:

31/12/2011

31/12/2010

31/12/2009

 

 

 

 

SUPPLIERS

1.136.655,02

1.244.468,00

1.221.930,00

LOANS AND FINANCING

349.143,67

1.803.969,00

3.552.394,00

SOCIAL / LABOR OBLIGATIONS

995.120,56

953.921,00

808.173,00

TRIBUTARY OBLIGATIONS

307.355,74

487.278,00

283.370,00

OTHER DEBTS

95.361,94

6.123,00

80.250,00

INSTALLMENTS TAXES PAYABLE

45.646,36

 

 

PROFIT SHARING

690.363,77

 

 

 

----------------

----------------

----------------

TOTAL CURRENT LIABILITIES

3.619.647,06

4.495.759,00

5.946.117,00

 

LONG TERM LIABILITIES:

 

 

 

 

 

 

 

LOANS AND FINANCING

921.686,29

276.960,00

308.911,00

TRIBUTARY OBLIGATIONS

 

2.656,00

140.228,00

TAX INCENTIVES

 

260.819,00

204.248,00

OTHER

 

 

134.335,00

 

----------------

----------------

----------------

TOTAL LONG TERM LIABILITIES

921.686,29

540.435,00

787.722,00

 

NET EQUITY:

 

 

 

 

 

 

 

SHARE CAPITAL

5.200.000,00

5.200.000,00

5.200.000,00

RESERVES/TAX INCENTIVES

8.503.059,65

7.208.402,00

5.952.835,00

ACCRUED PROFIT (LOSS)

560.583,73

-255.203,00

-417.605,00

 

----------------

----------------

----------------

TOTAL NET EQUITY

14.263.643,38

12.153.199,00

10.735.230,00

OFF-BALANCE ACCOUNTS

536.231,59

 

 

 

================

================

================

TOTAL LIABILITIES

19.341.208,32

17.189.393,00

17.469.069,00

 

PROFIT AND LOSS ACCOUNTS AS OF 31/12/2011, 31/12/2010 AND 31/12/2009.

( FIGURES ARE IN REAIS ).

 

 

31/12/2011

31/12/2010

31/12/2009

 

 

 

 

GROSS SALES

33.620.878,83

31.383.794,00

25.507.565,00

(-) TAXES ON SALES

5.377.044,00

4.836.213,00

3.939.190,00

 

----------------

----------------

----------------

NET SALES

28.243.834,83

26.547.581,00

21.568.375,00

(-) COST OF SOLD GOODS

18.208.709,73

18.798.100,00

16.477.775,00

 

----------------

----------------

----------------

GROSS PROFIT

10.035.125,10

7.749.481,00

5.090.600,00

OPERATING REVENUE (EXPENSE)

-7.598.008,53

-5.948.253,00

-5.119.513,00

FINANCIAL REVENUE(EXPENSE)

375.262,16

-724.669,00

-712.950,00

 

----------------

----------------

----------------

OPERATIONAL PROFIT (LOSS)

2.812.378,73

1.076.559,00

-741.863,00

CONTRIBUTION/INCOME TAX

-751.154,88

-259.554,00

-2.139,00

 

----------------

----------------

----------------

NET PROFIT (LOSS)

2.061.223,85

817.005,00

-744.002,00

 

MONTHLY SALES

 

  2011

 

 

 

---------------------

 

 

JANUARY

R$ 2.549.404,20

 

 

FEBRUARY

R$ 2.314.882,84

 

 

MARCH

R$ 4.023.255,86

 

 

APRIL

R$ 2.619.463,50

 

 

MAY

R$ 3.014.322,32

 

 

JUNE

R$ 2.646.800,63

 

 

JULY

R$ 2.903.900,16

 

 

AUGUST

R$ 2.859.801,41

 

 

SEPTEMBER

R$ 2.858.423,81

 

 

OCTOBER

R$ 2.476.281,78

 

 

NOVEMBER

R$ 2.506.302,84

 

 

DECEMBER

R$ 2.848.039,48

 

 

TOTAL

R$ 33.620.878,83

 

 

 

RATIOS:

31/12/2011

31/12/2010

31/12/2009

 

QUICK RATIO

2,21

 

1,50

 

1,05

 

CURRENT RATIO

2,87

 

2,06

 

1,57

 

ACCOUNTS RECEIVABLE TURNOVER

4,61

TIMES

4,35

TIMES

4,00

TIMES

DAYS' SALES IN RECEIVABLES

78,13

DAYS

82,73

DAYS

90,10

DAYS

INVENTORY TURNOVER

7,61

TIMES

7,49

TIMES

5,34

TIMES

ACCOUNTS PAYABLE PERIOD

22,47

DAYS

23,83

DAYS

26,70

DAYS

RETURN ON ASSETS

1,46

TIMES

1,54

TIMES

1,23

TIMES

SALES TURNOVER ON NET EQUITY

1,98

TIMES

2,18

TIMES

2,01

TIMES

NET WORTH TIE-UP

,53

 

,57

 

,71

 

INDEBTEDNESS

,32

 

,41

 

,63

 

EQUITY RATIO

73,75

%

70,70

%

61,45

%

WORKING CAPITAL RATIO

186,86

%

105,56

%

56,90

%

GENERAL SOLVENCY

4,26

 

3,41

 

2,59

 

RETURN ON NET EQUITY

14,45

%

6,72

%

-6,93

%

RETURN ON SALES (PROFIT MARGIN)

7,30

%

3,08

%

-3,45

%

GROSS PROFIT MARGIN

35,53

%

29,19

%

23,60

%

OPERATIONAL RESULT

9,96

%

4,06

%

-3,44

%

SALES TURNOVER ON LIABILITIES

7,80

TIMES

5,91

TIMES

3,63

TIMES

FOREIGN CURRENCY ON ASSETS

 

 

 

 

 

 

FOREIGN CURRENCY ON LIABILITIES

 

 

 

 

 

 

 

EXCHANGE RATE:

 

 

US$ 1,00 = R$ 2,03

 - OFFICIAL RATE ON 07/01/2013

US$ 1,00 = R$ 1,87

 - OFFICIAL RATE ON 31/12/2011

US$ 1,00 = R$ 1,66

 - OFFICIAL RATE ON 31/12/2010

US$ 1,00 = R$ 1,74

 - OFFICIAL RATE ON 31/12/2009

 

COMMENTS ON THE FINANCIAL INFORMATION:

 

FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS.

 

THE FIGURES AVAILABLE SHOW A GOOD FINANCIAL STANDING. IT SHOWS HIGH LIQUIDITY RATIOS WITH POSITIVE WORKING CAPITAL AMOUNT AND LOW LEVEL OF INDEBTEDNESS. IN ADDITION IT IS NOTED GROWING SALES AND PROFITABILITY.

 

REMARK:

 

THE 2011 FIGURES IS AN INTERIM BALANCE SHEET.

 

REAL ESTATE:

 

NOT AVAILABLE

 

VEHICLES:

 

NOT AVAILABLE

 

MACHINES:

 

NOT AVAILABLE

 

 

INSURANCE

 

NOT AVAILABLE.

 

 

BANKING REFERENCES

 

 

BRANCH/PHONE:

 

BANCO BRADESCO S/A

AG: 3684-6  /  62 3324-0541

 

BANCO DO BRASIL S/A

AG: 3388-X  /  62 3310-1640

 

BANCO ITAÚ S/A

AG: 4393  /  62 4093-4714

 

CAIXA ECONOMICA FEDERAL

AG: 2289  /  62 4014-1800

 

 

REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS.

 

ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682 BRAZILIAN CENTRAL BANK").

 

 

ACTIVITIES COMMENTS

 

SUBJECT IS ENGAGED IN THE MANUFACTURING AND TRADE OF PHARMACEUTICAL PRODUCTS FOR HUMAN USAGE.

 

IMPORT AND EXPORT:

 

IMPORTS FROM:

GERMANY, INDIA AND ITALY.

 

EXPORTS TO:

NOT AVAILABLE.

 

MAIN CLIENTS:

 

 

 

 

 

DOMESTIC CLIENTS:

 

PHONE:

ADEVAIR GROTO

 

65 3426-1998

CERVOSUL DISTRIBUIDORA FARMACÊUTICA LTDA

 

51 3230-4000

COMERCIAL CIRÚRGICA RIO CLARENSE

 

19 3522-5800

DIST. BRINGELL

 

92 2126-4000

DISTRIBUIDORA NAVARRO

 

11 3990-0881

DROGAFONTE LTDA

 

81 3428-1819

GAUCHA FARMA MEDICAMENTOS LTDA

 

51 3382-2000

HEALTHECNICA PRODS. HOSP. LTDA

 

11 3871-0326

MEGA MED 1600

 

21 2751-4701

MEIRELLES FARMA

 

84 3223-1410

 

STAFF:

 

THE COMPANY HAS: 280 EMPLOYEE(S)

 

 

CONCEPT AND FULFILMENT

 

THE SUBJECT IS A WELL-ESTABLISHED COMPANY, OPERATING SINCE 1977 WITH A GROWING SCALE OF ACTIVITIES. SO FAR IT HAS A CLEAR TRADE HISTORY AND GOOD PAYMENT BEHAVIOUR.

MAIN SUPPLIERS:

 

 

 

 

 

DOMESTIC SUPPLIERS:

 

PHONE:

BISFARMA IND. BEM. LTDA.

 

19 3893-3544

CARTOGRAFIA FENIX LTDA.

 

31 3361-6199

CIEL CONFIANÇA IMPORTAÇÃO E EXPORTAÇÃO LTDA

 

21 3535-9550

COLORCOM DO BRASIL LTDA

 

11 4617-8640

FARMAPLAST INDUSTRIA DE EMBALAGENS PLÁSTICAS LTDA

 

11 4612-2700

FORLAB-CHITEC S/A COM. E IND.

 

21 2232-0038

GERRESHEIMER

 

11 4613-1010

IMPACTA S/A

 

11 4447-7319

INDUKERN BRASIL

 

11 3689-7666

MACRON INDÚSTRIA GRÁFICA LTDA

 

11 4392-8156

PHARMA NOSTRA

 

0800-772-4880

PURIFARMA DISTRIBUIDORA QUIMICA E FARMACEUTICA LTDA

 

11 2272-5600

RACIONAL EMBALAGENS LTDA.

 

62 3586-3000

SUPRIMAX PAPEIS SUPRIMENTOS LTDA

 

62 3218-2233

VALDEQUIMICA PROD. QUÍMICOS LTDA.

 

11 3721-1077

THE COMPANY HAS TRADE RELATIONS WITH SEVERAL SUPPLIERS IN BRAZIL. THE SUPPLIERS EXTEND CREDIT FACILITIES TO THE SUBJECT IN TERMS AND AMOUNTS ACCORDING TO THE COMPANY'S NEEDS AND SO FAR NO PAYMENT PROBLEMS ARE NOTED.

 

PAYMENT HISTORY:

 

4 SUPPLIERS REPORTED PAYMENTS:

   TOTAL AMOUNT:  R$ 193.631,00

 

AMOUNT OF INVOICES PAID: 132

TOTAL OF PROMPT PAYMENTS: 99,3%

TOTAL OF DELAYED PAYMENTS: 0,7%

 

HIGHEST INVOICE: R$ 5.339,00

HIGHEST CREDIT: R$ 5.339,00

 

OUTSTANDING INVOICES DUE WITHIN THE NEXT 30 DAYS:

 

---------------------------

SUPPLIERS:

INVOICES:

TOTAL AMOUNT:

DUE WITHIN 30 DAYS

2

3

R$ 3.500,79

 

 

FINAL OPINION

 

THE SUBJECT IS A WELL-ESTABLISHED COMPANY IN BUSINESS FOR SEVERAL YEARS. UP TO DATE IT HAS A CLEAR TRADE HISTORY AND GOOD PAYMENT BEHAVIOUR.

 

BASED ON THE GENERAL INFORMATION AVAILABLE IT IS BELIEVED THAT GOOD TRADE RELATIONS MAY BE ESTABLISHED. CREDIT FACILITIES MAY BE EXTENDED WITHIN TERMS AND AMOUNTS ADEQUATE TO THE COMPANY'S FINANCIAL STRENGTH.

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.54.63

UK Pound

1

Rs.87.50

Euro

1

Rs.71.32

 

INFORMATION DETAILS

 

Report Prepared by :

SDA

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.